DCPH
Deciphera Pharmaceuticals LLC
NASDAQ: DCPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$25.59
+0.00% today
Updated 2026-04-30
Market cap
$2.21B
P/E ratio
—
P/S ratio
12.65x
EPS (TTM)
$-2.21
Dividend yield
—
52W range
$0 – $0
Volume
0.0M
Deciphera Pharmaceuticals LLC (DCPH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$25.59
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$53.59
Financial forecast
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.1B | $0.1B | $0.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -108.90%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.